Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306.4 USD | +0.54% | +0.16% | -1.75% |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
Apr. 25 | The specter of stagflation rears its ugly head again |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.92 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.71 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.75% | 77.87B | C+ | ||
-16.41% | 32.71B | B- | ||
-12.97% | 30.63B | A- | ||
-13.83% | 14.66B | B | ||
-3.81% | 13.83B | B+ | ||
-16.71% | 7.04B | B | ||
-8.10% | 6.89B | B- | ||
-14.49% | 2.75B | B- | ||
-15.90% | 2.71B | C+ | ||
-30.96% | 2.39B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SHW Stock
- Ratings The Sherwin-Williams Company